Picture of Sartorius Stedim Biotech SA logo

DIM — Sartorius Stedim Biotech SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Sartorius aims to grow again in 2024 after business slump

BERLIN, Jan 26 (Reuters) - Franco-German lab supplies
maker Sartorius  SATG.DE   STDM.PA  said on Friday it expects
sales revenue to increase again this year and laid out new
medium-term targets after a double-digit dip in 2023 due to
fading pandemic-related demand for lab equipment.
    For 2024, the company forecasts an increase in group sales
revenue in the mid-to-high single-digit percentage range, and
projects average double-digit annual growth through to 2028.
    In preliminary results, Sartorius reported a 16.6% decrease
in sales revenue, adjusted for currency effects, in 2023, which
was in line with its forecast of a dip of around 17%. 
    
    
 

 (Writing by Miranda Murray; Editing by Edmund Klamann)
 ((Miranda.Murray@thomsonreuters.com;))

Recent news on Sartorius Stedim Biotech SA

See all news